Asia-Pacific Americas Africa Europe Middle East

H. LUNDBECK A.S.

Company Profile:

H. Lundbeck A.S. India Company Introduction:

H. Lundbeck A.S. is a global pharmaceutical company headquartered in Denmark, dedicated to researching, developing, manufacturing, and marketing pharmaceutical products for the treatment of brain diseases. In India, Lundbeck focuses on the commercialization, sales, marketing, and distribution of its specialized portfolio of medicines. The company aims to provide innovative treatments to patients suffering from neurological and psychiatric disorders across the Indian subcontinent, ensuring access to its global pipeline of therapies and supporting healthcare professionals with relevant information and services.

Classification:

Trading Company

Enterprise Products

H. Lundbeck A.S. primarily focuses on the research, development, manufacturing, and marketing of pharmaceutical products for brain diseases. While Lundbeck is a Danish company, its products are sold globally, including in India, often through distributors or local partnerships.

The key products produced or sold by H. Lundbeck A.S. that are likely available or marketed in India include:

1. Trintellix (also known as Brintellix)

Active Ingredient: Vortioxetine

Indication: Major Depressive Disorder

2. Rexulti (also known as Plegridy)

Active Ingredient: Brexpiprazole

Indication: Schizophrenia, Major Depressive Disorder (as adjunctive therapy)

3. Abilify Maintena

Active Ingredient: Aripiprazole extended-release injectable suspension

Indication: Schizophrenia, Bipolar I Disorder

4. Vyepti

Active Ingredient: Eptinezumab

Indication: Migraine prevention

5. Austedo

Active Ingredient: Deutetrabenazine

Indication: Tardive Dyskinesia, Chorea associated with Huntington's Disease

6. Ebixa (also known as Axura)

Active Ingredient: Memantine

Indication: Alzheimer's Disease

7. Cipralex (also known as Lexapro)

Active Ingredient: Escitalopram

Indication: Depression, Anxiety Disorders (Note: While originally a Lundbeck product, it is often out-licensed or available as generics in many markets.)

The specific availability and brand names may vary based on local regulations and distribution agreements in India.

Business Registration Information:

Manager:

Charl van Zyl

Phone:

+45 36 30 13 11

E-mail:

No Data

Official Website:
Address:

Ottiliavej 9, 2500 Valby, Copenhagen, Denmark

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.